Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-22T15:00:26.198Z Has data issue: false hasContentIssue false

Aseptic meningitis caused by ECHO virus

Published online by Cambridge University Press:  15 May 2009

O. Lahelle
Affiliation:
Kaptein W. Wilhelmsen og Frues Bakteriologiske Institutt, Oslo University, Oslo, Norway
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. An investigation of ninety-eight cases of aseptic meningitis admitted to hospital resulted in the isolation of ECHO virus Type 6 from fifty-one patients.

2. The viruses were cultivated in both human embryonic skin-muscle tissue and human amniotic cell tissue. The latter was found to be more satisfactory.

3. Forty-eight strains were isolated from the stools of patients, six from the cerebrospinal fluid and four from throat-washings.

4. Serological examination of patients from whom the virus was isolated showed that a significant proportion of patients exhibited a specific antibody response. This included three out of six patients with the virus in their cerebrospinal fluid.

5. The clinical picture of aseptic meningitis from which cases ECHO virus was isolated cannot be distinguished from that caused by other known viruses.

6. The evidence presented supports the claim that ECHO virus Type 6 is one of the causes of aseptic meningitis.

Grateful appreciation is acknowledged to Prof. P. M. Holst (Oslo), Prof. Johs. Böe (Bergen), Dr B. Helland-Hanssen (Molde), Dr O. Römcke (Drammen), Dr R. Tingstad (Namsos), and Dr A. H. Brinchmann (Bærum), for providing specimens and case records. I am also grateful to Mrs B. Zapffe and Mrs L. Kohmann for expert technical assistance.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1957

References

REFERENCES

Committee on the ECHO Viruses (1955). Science, 122, 1187.CrossRefGoogle Scholar
Davies, D. C. & Melnick, J. L. (1956). Proc. Soc. exp. Biol., N.Y. 92, 839.CrossRefGoogle Scholar
Duncan, D., Silverthorne, N., McNaughton, G. A., Johnsson, C. C. R. & Rhodes, A. J. (1954). Canad. J. publ. Hlth, 45, 55.Google Scholar
Evaluation of 1954 Field Trial of Poliomyelitis Vaccine. Summary Report. Vaccine Evaluation Center, University of Michigan, Ann Arbor, Michigan, 12 04 1955.Google Scholar
Honig, E. I., Melnick, J. L., Isacson, P., Parr, R., Myers, I. L. & Walton, M. (1956). J. exp. Med. 103, 247.CrossRefGoogle Scholar
Lahelle, O. (1954). Acta path. microbiol. scand. 35, 119.CrossRefGoogle Scholar
Lahelle, O. (1956). Acta path. microbiol. scand. 39, 338.CrossRefGoogle Scholar
Lahelle, O. (1957 a). Nord. med. 57, 424.Google Scholar
Lahelle, O. (1957 b). Acta path. microbiol. scand. 40, 436.Google Scholar
Melnick, J. L. (1954). Amer. J. publ. Hlth, 44, 571.CrossRefGoogle Scholar
Ramos-Alvarez, M. & Sabin, A. B. (1954). Proc. Soc. exp. Biol., N.Y. 87, 655.CrossRefGoogle Scholar
Riordan, J. T., Ledinko, N. & Melnick, J. L. (1952). Amer. J. Hyg. 55, 339.Google Scholar
Robbins, F. C., Enders, J. F., Weller, T. H. & Florentino, G. L. (1951). Amer. J. Hyg. 54, 286.Google Scholar
Svedmyr, A., Melén, B. & Kjellén, L. (1956). Acta med. scand. 154, Suppl. 316, 20.CrossRefGoogle Scholar